Gossamer Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2016
Selling, General & Admin	37.89	38.46	47.61	45.78	49.73	39.14	Upgrade
Research & Development	129.87	135.3	170.92	170.27	160.85	143.4	Upgrade
Other Operating Expenses	10.02	10	0.07	0.08	23.38	3.6	Upgrade
Operating Expenses	177.78	183.76	218.59	216.12	233.96	186.14	Upgrade
Operating Income	-177.78	-183.76	-218.59	-216.12	-233.96	-186.14	Upgrade
Interest Expense / Income	13.14	13.51	13.88	19.44	12.67	1.94	Upgrade
Other Expense / Income	-18.34	-17.45	-3.1	-1.56	-3.27	-7.77	Upgrade
Pretax Income	-172.58	-179.82	-229.38	-234	-243.36	-180.31	Upgrade
Net Income	-172.58	-179.82	-229.38	-234	-243.36	-180.31	Upgrade
Shares Outstanding (Basic)	226	153	85	75	69	55	Upgrade
Shares Outstanding (Diluted)	226	153	85	75	69	55	Upgrade
Shares Change	137.94%	80.46%	13.00%	9.24%	25.16%	741.53%	Upgrade
EPS (Basic)	-1.00	-1.18	-2.71	-3.13	-3.55	-3.29	Upgrade
EPS (Diluted)	-1.00	-1.18	-2.71	-3.13	-3.55	-3.29	Upgrade
Free Cash Flow	-158.47	-159.16	-187.44	-190.44	-177.86	-147.8	Upgrade
Free Cash Flow Per Share	-0.70	-1.04	-2.22	-2.54	-2.60	-2.70	Upgrade
EBITDA	-155.21	-161.92	-211.07	-209.4	-226.43	-175.28	Upgrade
Depreciation & Amortization	4.23	4.39	4.43	5.17	4.27	3.09	Upgrade
EBIT	-159.44	-166.31	-215.5	-214.56	-230.69	-178.37	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).